Clinical Trial Update: Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a steroid-free regimen combining islet cell transplantation with CD34+ enriched bone marrow cell infusion in Type 1 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CD34+ enriched bone marrow cell infusion
• Islet cell transplantation

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED